AAM
KYTH

Aureus Asset Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Aureus Asset Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-112,702
Closed -$8.45M – 178
2015
Q3 		$8.45M Sell
112,702
-58,035
-34% -$4.33M 2.1% 21
2015
Q2 		$12.9M Buy
170,737
+40,430
+31% +$2.17M 2.7% 4
2015
Q1 		$6.54M Buy
130,307
+6,220
+5% +$261K 1.5% 33
2014
Q4 		$4.3M Sell
124,087
-15,005
-11% -$524K 1.05% 42
2014
Q3 		$4.56M Sell
139,092
-13,570
-9% -$478K 1.14% 42
2014
Q2 		$5.86M Buy
152,662
+16,357
+12% +$571K 1.46% 34
2014
Q1 		$5.42M Buy
136,305
+1,840
+1% +$82.3K 1.39% 35
2013
Q4 		$5.02M Buy
134,465
+42,115
+46% +$1.75M 1.36% 35
2013
Q3 		$4.21M Buy
+92,350
New +$2.76M 1.44% 37

Aureus Asset Management's KYTH Position: Q4 2015 in Review

Aureus Asset Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 112,702 shares — an estimated $8.45M sold.

Aureus Asset Management first reported a position in KYTH in Q3 2013 and held it in 9 quarters. The position peaked at $12.9M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Aureus Asset Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Aureus Asset Management sold 112,702 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $8.45M.
  • Aureus Asset Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 9 quarters.
  • Aureus Asset Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $12.9M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Aureus Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.